You are here

  • Home
  • Archive
  • Volume 14, Issue Suppl 1
  • OC63 The use of omegaven rescue therapy (ORT) in the treatment of intestinal failure associated liver disease (IFALD) in patients already received SMOF lipid: a tertiary single centre experience

Article info

Article menu
Download PDFPDF
Top of Form
OC63 The use of omegaven rescue therapy (ORT) in the treatment of intestinal failure associated liver disease (IFALD) in patients already received SMOF lipid: a tertiary single centre experience

Authors

Citation

Chew K, Motion J, Fraser S, et al
OC63 The use of omegaven rescue therapy (ORT) in the treatment of intestinal failure associated liver disease (IFALD) in patients already received SMOF lipid: a tertiary single centre experience
Frontline Gastroenterology 2023;14:A38-A39.

Publication history

  • First published July 27, 2023.
Online issue publication 
July 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.